An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

NCT03510884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolaemia

Interventions

DRUG: Alirocumab SAR236553 (REGN727)
DRUG: Rosuvastatin
DRUG: Atorvastatin
DRUG: Simvastatin
DRUG: Pravastatin
DRUG: Lovastatin
DRUG: Fluvastatin
DRUG: Ezetimibe
DRUG: Cholestyramine
DRUG: Nicotinic acid
DRUG: Fenofibrate
DRUG: Omega-3 fatty acids
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]